Sigyn Therapeutics, Inc. (OTCMKTS:SIGY – Get Free Report) shares traded down 24.6% during trading on Friday . The stock traded as low as $4.07 and last traded at $4.07. 325 shares changed hands during mid-day trading, a decline of 48% from the average session volume of 629 shares. The stock had previously closed at $5.40.
Sigyn Therapeutics Stock Down 24.6 %
The business has a 50 day moving average price of $5.41 and a two-hundred day moving average price of $5.43.
About Sigyn Therapeutics
Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.
Further Reading
- Five stocks we like better than Sigyn Therapeutics
- What Are Trending Stocks? Trending Stocks Explained
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Market Cap Calculator: How to Calculate Market Cap
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Where to Find Earnings Call Transcripts
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
